Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers
1First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Insights
Human T-cell leukemia virus type I (HTLV-I) carriers show impaired immune cell function, including reduced T-cell and B-cell responses, despite normal cytotoxic T-cell activity. These immunological changes may contribute to adult T-cell leukemia (ATL) development.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Human T-cell leukemia virus type I (HTLV-I) infection is linked to adult T-cell leukemia (ATL).
- Understanding early immunological changes in asymptomatic carriers is crucial for predicting disease progression.
Purpose of the Study:
- To investigate the in vitro immunological functions of peripheral blood lymphocytes (PBL) from HTLV-I-seropositive healthy carriers.
- To identify specific immune cell abnormalities associated with HTLV-I infection in carriers.
Main Methods:
- In vitro analysis of peripheral blood lymphocytes (PBL) from HTLV-I carriers and normal controls.
- Assays for proliferative responses to T-cell and B-cell mitogens (Con A, PWM, SAC).
- Flow cytometry to analyze cell surface phenotypes (CD3, CD4, CD8, CD25) and immunoglobulin production.
Main Results:
- HTLV-I carriers exhibited moderately impaired PBL proliferative responses and immunoglobulin production.
- Cytotoxic T-cell activity was not impaired, while natural killer-cell activity was slightly decreased.
- Significant decreases in CD3+ and CD4+ cell percentages and MFI, with increased CD25+ cells, were observed in carriers.
Conclusions:
- Early immunological abnormalities, including altered T-cell subsets, are present in HTLV-I carriers.
- These immune dysfunctions may play a role in the leukemogenesis of adult T-cell leukemia (ATL) following HTLV-I infection.
Abstract:
We studied immunological functions of peripheral blood lymphocytes (PBL) from human T-cell leukemia virus type I (HTLV-I)-seropositive healthy carriers in vitro. Proliferative responses of PBL to T-cell and B-cell mitogens such as concanavalin A (Con A), pokeweed mitogen (PWM), and Staphylococcus aureus Cowan I (SAC) were moderately impaired in HTLV-I carriers compared with normal controls. Immunoglobulin (Ig)-producing activity of PBL stimulated with B-cell mitogens were also impaired in HTLV-I carriers. However, cytotoxic T-cell activity induced by in vitro culture was not impaired but slightly increased in HTLV-I carriers. Natural killer-cell activity was only slightly decreased. By a flow cytofluorometric analysis of the cell surface phenotypes of PBL, the percentage and the mean fluorescence intensity (MFI) of CD 3-positive cells and CD 4-positive cells were significantly decreased in HTLV-I carriers. The percentage and the MFI of CD 8-positive cells was not changed. The percentage and the MFI of CD 25-positive cells were increased. These results suggest that some immunological abnormalities are already present in HTLV-I carriers and such abnormalities have some roles for the leukemogenesis from the infection of the HTLV-I into adult T-cell leukemia (ATL).
More Related Videos
Related Concept Videos
Cell-mediated Immune Responses
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...


